REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT
KR Raveendra, Chirag Rathod, Rahul Darnule, View ORCID ProfileSubramanian Loganathan, Sarika Deodhar, A Radhika, Ashwani Marwah, Nitin M Chaudhari, Binay K Thakur, Sivakumar Vaidyanathan, Sandeep Nilkanth Athalye
doi: https://doi.org/10.1101/2021.10.25.21265462
KR Raveendra
1Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India
Chirag Rathod
2GMERS Medical College & Hospital, Old TB Hospital Campus, Vadodara, Gujarat, India
Rahul Darnule
3Saint George’s Hospital, Mumbai, Maharashtra, India
Subramanian Loganathan
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Sarika Deodhar
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
A Radhika
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Ashwani Marwah
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Nitin M Chaudhari
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Binay K Thakur
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Sivakumar Vaidyanathan
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
Sandeep Nilkanth Athalye
4Clinical Development and Medical Affairs, Biocon Biologics Ltd, Bengaluru, Karnataka, India
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted October 28, 2021.
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT
KR Raveendra, Chirag Rathod, Rahul Darnule, Subramanian Loganathan, Sarika Deodhar, A Radhika, Ashwani Marwah, Nitin M Chaudhari, Binay K Thakur, Sivakumar Vaidyanathan, Sandeep Nilkanth Athalye
medRxiv 2021.10.25.21265462; doi: https://doi.org/10.1101/2021.10.25.21265462
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT
KR Raveendra, Chirag Rathod, Rahul Darnule, Subramanian Loganathan, Sarika Deodhar, A Radhika, Ashwani Marwah, Nitin M Chaudhari, Binay K Thakur, Sivakumar Vaidyanathan, Sandeep Nilkanth Athalye
medRxiv 2021.10.25.21265462; doi: https://doi.org/10.1101/2021.10.25.21265462
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12136)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4032)
- Geriatric Medicine (380)
- Health Economics (670)
- Health Informatics (2607)
- Health Policy (994)
- Hematology (359)
- HIV/AIDS (832)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3798)
- Nursing (208)
- Nutrition (564)
- Oncology (1989)
- Ophthalmology (577)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6471)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)